- Home
- TAIT vs GOVX Comparison
TAIT vs GOVX Comparison
Compare TAIT & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAIT
- GOVX
- Stock Information
- Founded
- TAIT 1989
- GOVX 2001
- Country
- TAIT United States
- GOVX United States
- Employees
- TAIT N/A
- GOVX N/A
- Industry
- TAIT Electronic Components
- GOVX Biotechnology: Pharmaceutical Preparations
- Sector
- TAIT Technology
- GOVX Health Care
- Exchange
- TAIT Nasdaq
- GOVX Nasdaq
- Market Cap
- TAIT 13.3M
- GOVX 15.5M
- IPO Year
- TAIT 1995
- GOVX N/A
- Fundamental
- Price
- TAIT $2.18
- GOVX $0.95
- Analyst Decision
- TAIT
- GOVX Strong Buy
- Analyst Count
- TAIT 0
- GOVX 5
- Target Price
- TAIT N/A
- GOVX $12.40
- AVG Volume (30 Days)
- TAIT 16.6K
- GOVX 1.5M
- Earning Date
- TAIT 08-13-2025
- GOVX 08-05-2025
- Dividend Yield
- TAIT 9.21%
- GOVX N/A
- EPS Growth
- TAIT N/A
- GOVX N/A
- EPS
- TAIT 0.01
- GOVX N/A
- Revenue
- TAIT $4,260,000.00
- GOVX $5,591,576.00
- Revenue This Year
- TAIT N/A
- GOVX N/A
- Revenue Next Year
- TAIT N/A
- GOVX N/A
- P/E Ratio
- TAIT $225.79
- GOVX N/A
- Revenue Growth
- TAIT N/A
- GOVX N/A
- 52 Week Low
- TAIT $2.01
- GOVX $0.73
- 52 Week High
- TAIT $3.05
- GOVX $11.18
- Technical
- Relative Strength Index (RSI)
- TAIT 47.75
- GOVX 46.22
- Support Level
- TAIT $2.15
- GOVX $0.85
- Resistance Level
- TAIT $2.28
- GOVX $1.39
- Average True Range (ATR)
- TAIT 0.07
- GOVX 0.15
- MACD
- TAIT 0.00
- GOVX -0.02
- Stochastic Oscillator
- TAIT 28.00
- GOVX 18.52
About TAIT Taitron Components Incorporated
Taitron Components Inc is a supplier of originally designed and manufactured (ODM) products that include value-added engineering and turn-key solutions. It focuses on providing original equipment manufacturers (OEMs) and contracts electronic manufacturers (CEMs) with ODM products for their multi-year turn-key projects and ODM electronic components. The company's product offerings range from discrete semiconductors to small electronic devices. The company also distributes brand-name electronic components with a vast inventory available on hand. Its Taiwan and China locations, provide support for inventory sourcing, purchases, and coordinating the manufacture of ODM Projects and ODM Components.
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.